Gordon Tomaselli, M.D.

Highlights of Dean Tomaselli’s Tenure

The five-year term (2018 to 2023) of Gordon Tomaselli, M.D., Einstein’s Marilyn and Stanley M. Katz Dean, was dominated by a global pandemic as well as unprecedented financial stresses on the College of Medicine that required enormous adaptation. Despite those considerable challenges, Einstein and Montefiore not only endured but also moved forward with a number of remarkable and, in some cases, transformative accomplishments in research, education, organizational structure, and operations. Some of those are listed below.

These and other efforts contributed to Einstein being recognized in 2022 as one of the 500 best midsize employers in the U.S. among educational institutions, according to Forbes. Einstein ranked No. 1 in New York City, No. 2 in New York State, and No. 35 nationally.

Research Enterprises

Recruited Edward Chu, M.D., as the new director of the renamed Montefiore Einstein Cancer Center (MECC), whose mission is to better integrate cancer science and discovery at the College of Medicine into Montefiore Health System. MECC had a successful National Cancer Institute site visit in January, with positive results expected in May.
Launched a program of collaborating laboratories designed to help manage and ultimately eliminate the COVID-19 virus as a threat to public health.
Worked on developing new diagnostic approaches to disease through the office of biotechnology and business development.
Collaborated with the New York City Economic Development Corporation to provide funding to Einstein with the goal of becoming a leading life sciences hub for research and innovation in the tristate area.
Attained record levels of National Institutes of Health funding, which totaled more than $200 million for the first time in 2020 and again in 2022.

Academic Initiatives

Became a fully independent degree-granting medical school, completing its transition from Yeshiva University into Montefiore Medicine Academic Health.
Created a new, innovative medical school curriculum, a process that was accelerated by the COVID-19 pandemic.
Consolidated Einstein’s academic departments with the goal of further advancing science and collaboration while improving thematic clustering of prioritized research.
Began intense preparation for Einstein’s reaccreditation by the Liaison Committee for Medical Education (LCME), a process that takes place every eight years. The successful LCME site visit took place in January, with positive results expected this spring.
Solidified the leadership and institutional importance of the Belfer Institute for Advanced Biomedical Studies.

Additional Achievements

Received a $100M gift from an anonymous donor to support Einstein’s research and education programs.
Strengthened our diversity and inclusion programs and initiatives.
Reevaluated and reorganized our development programs, with the goal of increasing private philanthropy at Einstein.
Made major changes to Einstein’s Board of Trustees, including the addition of 12 new Board members.
Upgraded Einstein’s infrastructure, with an emphasis on improving information technology operations.

Healing Child and Teen Mental Health

Healing Child and Teen Mental Health

Mentorship Matters to Scientists

Launching Medicine’s Next Innovators

Translating Discoveries Into Therapies

Mavens of Medicine: Melissa Wasserstein

A Message From the Dean